Overdiagnosis, an absent concept in the information for females in the public program of breast cancer screening in Spain
Section: Originals
How to quote
Nadal Fuster A, Ramazanova A, Álvarez-Dardet Díaz C. Sobrediagnóstico, un concepto que falta en la información para las mujeres de los programas de cribado de cáncer de mama en España. RIdEC 2019; 12(1):52-7.
Authors
1 Andrea Nadal Fuster, 1 Alina Ramazanova, 2 Carlos Álvarez-Dardet Díaz
Position
1 Enfermera. Universidad de Alicante.2 Grupo de Investigación en Salud Pública. Universidad de Alicante.
Abstract
Purpose: overdiagnosis is to diagnose a process that left to its own evolution will never produce damages. The overdiagnosis in the screening of breast cancer is a public health problem and a subject of current controversy among researches because it brings iatrogenic disease associated with overtreatment. The aims of this study were to value the the information about overdiagnosis in the Early Breast Cancer Detection Programs of Spain and the age ranges recommended by them.
Methods: a review was made of the information available on the web pages of the Health Ministries of the 17 Spanish Autonomous Communities and the cities of Ceuta and Melilla, about mammographic screening at 2017.
Results: five of the 19 Early Breast Cancer Screening Programs adress the overdiagnosis. There is a disagreement between the Autonomous Communities and spanish cities about the available information related to the suggested age range for mammographic screening.
Conclusions: it is necessary consider an update of the Breast Cancer Early Detection Programs by their managers so that the beneficiearies women can make informed decisions about their health based on the best available scientific evidence.
Keywords:
overdiagnosis; Screening; breast cancer; iatrogenic disease
Versión en Español
Título:
Artículo completo no disponible en este idioma / Full article is not available in this language
Bibliography
[1] Ascunce N. Sobrediagnóstico en programas de cribado de cáncer de mama: un efecto adverso inevitable que debe tenerse en cuenta. Med Clin. 2015; 144:161-2.
(2] Etzioni R, Xia J, Hubbard R, Weiss NS, Gulati R. A reality check for overdiagnosis estimates associated with breast cancer screening. JNCI: Journal of the National Cancer Institute. 2014; 106.
(3] Cervera Deval J, Sentís Crevillé M, Zulueta JJ. Sobrediagnóstico en cribado de cáncer. Radiología. 2015; 57:188-92.
(4] Apesteguía Ciriza L, Pina Insausti LJ. Cribado poblacional de cáncer de mama. Certezas, controversias y perspectivas de futuro. Radiología. 2014; 56:479-84.
(5] Autier P, Boniol M, Koechlin A, Pizot C. Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study. The BMJ. 2017; 359:5224.
(6] Martínez-Alonso M, Vilaprinyo E, Marcos-Gragera R, Rue M. Breast cancer incidente and overdiagnosis in Catalonia (Spain). Breast Cancer Research. 2010; 12.
(7] Sankaranarayanan R. Screening for cancer in low-and middle-income countries. Annals of global health. 2014; 80:412-7.
(8] Ballesteros-Peña S, Gavilán-Moral E. Contenido de los documentos informativos dirigidos a las mujeres sobre el cribado de cáncer de mama en España. Rev. Esp. Salud Publica 2018; 92.
(9] Hersch J, Barratt A, Jansen J, Irwig L, McGeechan K, Jacklyn G, et al. Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial. The Lancet. 2015; 385:1642-52.
(10] Pérez-Lacasta MJ, Martínez-Alonso M, García M, Sala M, Perestelo-Pérez L, Vidal C, et al. Effect of information about the benefits and harms of mammography on women’s decision making: The InforMa randomised controlled trial. PLoS ONE 2019; 14(3):e0214057. https://doi.org/10.1371/journal.pone.0214057
(11] Hoffmann TC, Del Mar C. Patients’ expectations of the benefits and harms of treatments, screening, and tests. A systematic review. JAMA Internal Medicine. 2015; 175:274-86.
(12] Ministerio de Sanidad y Política Social. Estrategia en Cáncer del Sistema Nacional de Salud [internet]. Ministerio de Sanidad, Servicios Sociales e Igualdad. 2010 [citado 8 may 2019]; 1-16. Disponible en: https://www.mscbs.gob.es/organizacion/sns/planCalidadSNS/pdf/ActualizacionEstrategiaCancer.pdf
(13] Baena-Cañada JM, Rosado-Varela P, Expósito-Álvarez I, González-Guerrero M, Nieto-Vera J, Benítez-Rodríguez E. Women’s perceptions of breast cancer screening. Spanish screening programme survey. The breast. 2014; 23:883-8.
(14] Ascunce N, Barcos A, Ederra M, Erdozain N, Murillo A, Osa A, et al. Programas de detección precoz de cáncer de mama en España: características y principales resultados. Med Clin. 2013; 141:13-23.
